The Fifth Circuit's ruling in Louisiana v. FDA could eliminate mail and pharmacy access to mifepristone nationwide. @uclarepropolicy.bsky.social filed an amicus brief urging SCOTUS to reverse the decision. Here, @melissagoodman.bsky.social, CRHLP’s executive director, explains what's at stake.
law.ucla.edu
The executive director from UCLA Law’s Center on Reproductive Health, Law, and Policy discusses the center's joint amicus brief in the US Supreme Court case, Louisiana v. FDA.
